TY - JOUR
T1 - Shared Decision-Making for a Dialysis Modality
AU - Yu, Xueqing
AU - Nakayama, Masaaki
AU - Wu, Mai Szu
AU - Kim, Yong Lim
AU - Mushahar, Lily
AU - Szeto, Cheuk Chun
AU - Schatell, Dori
AU - Finkelstein, Fredric O.
AU - Quinn, Robert R.
AU - Duddington, Michelle
N1 - Funding Information:
We thank Dr. Mark Marshall, former director of Medical Affairs, Baxter Healthcare (Asia Pacific), for providing the initial concept for this review and for conducting advisory board meetings. We also thank the participants of the predialysis SDM advisory board meetings that took place in 2019. This review was funded by Baxter Australia who provided financial support for medical writing assistance. We thank Cameron Ward, AMICULUM Ltd. for medical editorial assistance with this manuscript. This review was funded by Baxter Australia who provided financial support for medical writing assistance.
Funding Information:
We thank Dr. Mark Marshall, former director of Medical Affairs, Baxter Healthcare (Asia Pacific), for providing the initial concept for this review and for conducting advisory board meetings. We also thank the participants of the predialysis SDM advisory board meetings that took place in 2019. This review was funded by Baxter Australia who provided financial support for medical writing assistance. We thank Cameron Ward, AMICULUM Ltd., for medical editorial assistance with this manuscript. This review was funded by Baxter Australia who provided financial support for medical writing assistance.
Publisher Copyright:
© 2021 International Society of Nephrology
PY - 2022/1
Y1 - 2022/1
N2 - The prevalence of kidney failure continues to rise globally. Dialysis is a treatment option for individuals with kidney failure; after the decision to initiate dialysis has been made, it is critical to involve individuals in the decision on which dialysis modality to choose. This review, based on evidence arising from the literature, examines the role of shared decision-making (SDM) in helping those with kidney failure to select a dialysis modality. SDM was found to lead to more people with kidney failure feeling satisfied with their choice of dialysis modality. Individuals with kidney failure must be cognizant that SDM is an active and iterative process, and their participation is essential for success in empowering them to make decisions on dialysis modality. The educational components of SDM must be easy to understand, high quality, unbiased, up to date, and targeted to the linguistic, educational, and cultural needs of the individual. All individuals with kidney failure should be encouraged to participate in SDM and should be involved in the design and implementation of SDM approaches.
AB - The prevalence of kidney failure continues to rise globally. Dialysis is a treatment option for individuals with kidney failure; after the decision to initiate dialysis has been made, it is critical to involve individuals in the decision on which dialysis modality to choose. This review, based on evidence arising from the literature, examines the role of shared decision-making (SDM) in helping those with kidney failure to select a dialysis modality. SDM was found to lead to more people with kidney failure feeling satisfied with their choice of dialysis modality. Individuals with kidney failure must be cognizant that SDM is an active and iterative process, and their participation is essential for success in empowering them to make decisions on dialysis modality. The educational components of SDM must be easy to understand, high quality, unbiased, up to date, and targeted to the linguistic, educational, and cultural needs of the individual. All individuals with kidney failure should be encouraged to participate in SDM and should be involved in the design and implementation of SDM approaches.
KW - continuous renal replacement therapy
KW - education
KW - hemodialysis
KW - peritoneal dialysis
UR - http://www.scopus.com/inward/record.url?scp=85119424962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119424962&partnerID=8YFLogxK
U2 - 10.1016/j.ekir.2021.10.019
DO - 10.1016/j.ekir.2021.10.019
M3 - Review article
AN - SCOPUS:85119424962
SN - 2468-0249
VL - 7
SP - 15
EP - 27
JO - Kidney International Reports
JF - Kidney International Reports
IS - 1
ER -